|
GB9622386D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
|
AU6279598A
(en)
|
1997-02-18 |
1998-09-08 |
Neurocrine Biosciences, Inc. |
Biazacyclic CRF antagonists
|
|
CN1268137A
(zh)
|
1997-07-03 |
2000-09-27 |
杜邦药品公司 |
治疗神经失调的咪唑并嘧啶和咪唑并吡啶
|
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
|
US6365589B1
(en)
*
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
|
US6124463A
(en)
*
|
1998-07-02 |
2000-09-26 |
Dupont Pharmaceuticals |
Benzimidazoles as corticotropin release factor antagonists
|
|
US6271380B1
(en)
*
|
1998-12-30 |
2001-08-07 |
Dupont Pharmaceuticals Company |
1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
|
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
JP2003510327A
(ja)
|
1999-09-30 |
2003-03-18 |
ニューロジェン・コーポレーション |
特定のアルキレンジアミンで置換された複素環
|
|
JP2003516992A
(ja)
|
1999-12-17 |
2003-05-20 |
デュポン ファーマシューティカルズ カンパニー |
イミダゾピリミジニル誘導体およびイミダゾピリジニル誘導体
|
|
EP1293213A1
(en)
*
|
2000-02-14 |
2003-03-19 |
Japan Tobacco Inc. |
Preventives/remedies for postoperative stress
|
|
JP2004531475A
(ja)
|
2001-01-26 |
2004-10-14 |
ブリストル−マイヤーズ スクイブ カンパニー |
コルチコトロピン放出因子阻害剤としてのイミダゾリル誘導体
|
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
WO2002076984A1
(en)
*
|
2001-03-23 |
2002-10-03 |
Smithkline Beecham Corporation |
Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
|
|
MXPA03009738A
(es)
|
2001-04-27 |
2004-01-29 |
Eisai Co Ltd |
Pirazol [1,5-a] piridinas y medicinas que las contienen.
|
|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
|
DE60326869D1
(de)
*
|
2002-10-22 |
2009-05-07 |
Eisai R&D Man Co Ltd |
7-phenylpyrazolopyridinverbindungen
|
|
BRPI0406761A
(pt)
|
2003-01-14 |
2005-12-20 |
Arena Pharm Inc |
Derivados de arila e heteroarila 1,2,3-trissubstituìdos como moduladores do metabolismo e a profilaxia e tratamento de distúrbios relacionados a estes tais como diabetes e hiper-glicemia
|
|
US7034023B2
(en)
*
|
2003-04-04 |
2006-04-25 |
Pfizer Inc |
Pyrrolo[1,2-B]pyridazine compounds and their uses
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
US20070021429A1
(en)
*
|
2003-04-09 |
2007-01-25 |
Yves St-Denis |
Condensed n-heterocyclic compounds and their use as crf receptor antagonists
|
|
RS20060018A
(en)
|
2003-07-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
|
US20060024661A1
(en)
*
|
2003-07-30 |
2006-02-02 |
The Regents Of The University Of California |
Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
|
|
RU2367663C2
(ru)
|
2004-01-06 |
2009-09-20 |
Тайсо Фармасьютикал Ко., Лтд. |
Производные пирролопиримидина и пирролотриазина
|
|
WO2005066182A1
(en)
|
2004-01-06 |
2005-07-21 |
Taisho Pharmaceutical Co., Ltd. |
Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
|
|
DE602005014955D1
(de)
*
|
2004-03-26 |
2009-07-30 |
Lilly Co Eli |
Verbindungen und verfahren zur behandlung von dyslipidämie
|
|
GB0428475D0
(en)
*
|
2004-12-30 |
2005-02-02 |
4 Aza Bioscience Nv |
Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
|
|
DE102005007160A1
(de)
|
2005-02-16 |
2006-08-24 |
Basf Ag |
Pyrazolcarbonsäureanilide, Verfahren zu ihrer Herstellung und sie enthaltende Mittel zur Bekämpfung von Schadpilzen
|
|
US8232278B2
(en)
*
|
2005-06-24 |
2012-07-31 |
Gilead Sciences, Inc. |
Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C
|
|
US8338435B2
(en)
*
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
|
TW200840584A
(en)
*
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008077650A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008077649A1
(en)
*
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
|
CN102007133B
(zh)
|
2008-04-15 |
2013-06-12 |
卫材R&D管理有限公司 |
3-苯基吡唑并[5,1-b]噻唑化合物
|
|
WO2009152584A1
(en)
*
|
2008-06-20 |
2009-12-23 |
Macquarie University |
Synthesis of ageladine a and analogs thereof
|
|
WO2010002998A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Gilead Sciences, Inc. |
2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
|
|
EP2331095B1
(en)
|
2008-08-04 |
2014-10-15 |
CHDI Foundation, Inc. |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
|
US20120220581A1
(en)
|
2009-10-30 |
2012-08-30 |
Janssen-Cilag, S.A. |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
AU2011305525B2
(en)
|
2010-09-22 |
2016-08-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the GPR119 receptor and the treatment of disorders related thereto
|
|
CN102796133B
(zh)
*
|
2011-05-27 |
2015-05-20 |
北京大学 |
一种稀土铕配合物及其作为发光材料的应用
|
|
CA2838645C
(en)
|
2011-06-27 |
2020-03-10 |
Janssen Pharmaceutica Nv |
1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
|
|
CA2844128C
(en)
|
2011-08-30 |
2020-09-01 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
US9428464B2
(en)
|
2011-08-30 |
2016-08-30 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
US9669035B2
(en)
|
2012-06-26 |
2017-06-06 |
Janssen Pharmaceutica Nv |
Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
|
|
ES2607184T3
(es)
|
2012-07-09 |
2017-03-29 |
Janssen Pharmaceutica, N.V. |
Inhibidores de la enzima fosfodiesterasa 10
|
|
EP3024836B1
(de)
*
|
2013-07-23 |
2018-07-11 |
Bayer CropScience Aktiengesellschaft |
Verbessertes verfahren zur herstellung von chlorierten biphenylaniliden und biphenylanilinen
|
|
AU2015289492B2
(en)
|
2014-07-17 |
2020-02-20 |
Chdi Foundation, Inc. |
Methods and compositions for treating HIV-related disorders
|
|
AU2016205361C1
(en)
|
2015-01-06 |
2021-04-08 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
IL285890B
(en)
|
2015-06-22 |
2022-07-01 |
Arena Pharm Inc |
Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
|
|
CN110770227B
(zh)
|
2017-06-30 |
2024-03-01 |
拜耳动物保健有限责任公司 |
新的氮杂喹啉衍生物
|
|
CN113302175A
(zh)
|
2018-11-09 |
2021-08-24 |
维瓦斯治疗公司 |
双环化合物
|
|
US20230087801A1
(en)
|
2019-01-14 |
2023-03-23 |
Qingdao Kingagroot Chemical Compound Co., Ltd. |
4-pyridinyl formamide compound or derivative thereof, preparation method therefor, herbicidal composition and use thereof
|
|
US11420935B2
(en)
|
2019-04-16 |
2022-08-23 |
Vivace Therapeutics, Inc. |
Bicyclic compounds
|
